StockData
IMCCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

IM Cannabis Corp.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 30, 2026
$1.50+0.11 (+7.91%)

Close on Oct 19, 2026

IM Cannabis Corp. balance sheet

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin
17.7%
Operating margin
-21.2%
Net margin
-20.7%
Return on equity, FY2025
-1496.2%

Financial strength

Current ratio
0.56
Debt to equity
-2.18
Debt to assets
48.9%
Cash to current liabilities
5.5%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

Valuation ratios need the share price and fill in once daily prices are connected.